– CNBC
Eiger Shares Tumble Despite Phase 3 Study Meets Primary Endpoint
Eiger BioPharmaceuticals Inc (NASDAQ:EIGR) announced topline primary Week 48 data from its Phase 3 D-LIVR study of lonafarnib in two regimens in patients…
Related Posts
Statement from Samuel Levine, Director Of FTC Bureau Of Consumer Protection, Regarding The Commission’s Order And Opinion In The Intuit TurboTax Case
https://www.ftc.gov/news-events/news/press-releases/2024/01/statement-samuel-levine-director-ftc-bureau-consumer-protection-regarding-commissions-order-opinionFollowing is a statement from Samuel Levine, Director of the
Huntington Ingalls Bags $1.3B Contract To Support US Africa Command’s Life-Saving Operations
Huntington Ingalls Industries Inc (NYSE:HII) Mission Technologies division has secured the $1.3 billion U.S. Africa Command (USAFRICOM) Personnel Recovery…